small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (148)
  • Capabilities (46)
  • Experience (14)
  • Insights & News (487)
  • Other Results (35)

Professionals 148 results

Becky Troutman
Becky Troutman
Partner
  • San Francisco, 
  • Silicon Valley
Email
+1 415-591-1401
vCard

Partner

  • San Francisco
  • Silicon Valley
Gino Cheng
Gino Cheng
Partner
  • Miami
Email
+1 305-910-0582
vCard

Partner

  • Miami
Alan Roth
Alan Roth
Partner
  • Chicago
Email
+1 312-558-6474
vCard

Partner

  • Chicago
View All Professionals

Capabilities 46 results

Practice Area

IP Licensing & Due Diligence

We routinely help clients protect and commercialize their intellectual property (IP) assets and provide due diligence on complex technology and IP transactions. We negotiate and draft IP licenses and transfers; provide strategic guidance on optimal structures for IP and IT transactions; and evaluate copyright, trademark, and patent portfolios and provide related due diligence activities in connection with IPOs, mergers and acquisitions, private equity investments, licenses, and other corporate transactions....Read more

Practice Area

Trademark Litigation, Prosecution & Brand Protection

Industry

Media & Entertainment

For decades, Winston has filled a unique niche in the media and entertainment industry, and we continue to be at the forefront of today’s most important and challenging cases. Our interdisciplinary team advises some of the world’s most prominent industry players—studios, production companies, entertainers, artists, athletes, other celebrities, and other sector participants—in connection with the disputes and deals that are moving this dynamic industry forward....Read more

Experience 14 results

Experience

|

January 19, 2024

ITC ALJ Issues Win for AMD

Experience

|

August 1, 2023

American Multinational Hedge Fund and Financial Services Company Trademark Counseling

Experience

|

June 16, 2023

Hudson Ferry Capital Sale of Ground/Water Treatment & Technology

View All Experience

Insights & News 487 results

Client Alert

|

May 22, 2025

|

8 Min Read

The En Banc Federal Circuit Clarifies What Evidence May Be Relied on for Proving Reasonable Royalty Damages

EcoFactor, Inc. v. Google LLC, Case No. 2023-1101 (Fed. Cir. May 21, 2025) (en banc)...Read more

Press Release

|

May 21, 2025

|

1 Min Read

Winston & Strawn Launches Financial Innovation & Regulation Practice

Miami—May 21, 2025—Winston & Strawn LLP is pleased to announce the launch of its Financial Innovation & Regulation Practice (FIR), a strategic response to the rapidly evolving financial services landscape and the increasingly complex legal and regulatory issues that confront companies at the forefront of innovation....Read more

Article

|

May 13, 2025

|

9 Min Read

The New DOJ Enforcement Policy for Digital Assets: Why Compliance Programs Still Matter

This article was originally published in New York Law Journal. Any opinions in this article are not those of Winston & Strawn or its clients. The opinions in this article are the authors’ opinions only. ...Read more
View All Insights & News

Other Results 35 results

Law Glossary

What Is Copyright Licensing?

An original work of authorship that is fixed in a tangible form and exhibits at least a minimal amount of creativity may be protected by U.S. copyright law. Under the law, a copyright owner has various exclusive rights to use the protected work, including the right to make copies of it; create derivative works based on it; and distribute it to the public. For certain types of works, the copyright owner also has the exclusive right to publicly perform or publicly display the work....Read more

Law Glossary

What Is the Standard for the FDA to Grant a Biosimilar License?

Granting a Biosimilar License...Read more

Law Glossary

What Is the Standard for the FDA to Grant a Generic Drug License?

An Abbreviated New Drug Application (ANDA) must contain evidence that the proposed generic drug product is bioequivalent to the reference drug....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising